Skip to main content

LOS ANGELES CAPITAL MANAGEMENT LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1177206 LOS ANGELES, CA

Position in ALNY

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$29,208,541
-$66,248,136 QoQ
Shares Held
88,278
-63.2% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2022
14 quarters on record
Voting authority Sole 18.058859511996197.ToString("F0")% Shared 0.ToString("F0")% None 81.94114048800381.ToString("F0")%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

LOS ANGELES CAPITAL MANAGEMENT LLC holds $690,323,052 across 153 Biotechnology names. ALNY ranks #7 (4.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 ALNY
Alnylam Pharmaceuticals, Inc.
This page
88,278 $29,208,541

All Filings in ALNY

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $29,208,541 88,278
2025-12-31 $95,456,677 240,052
2025-09-30 $72,683,664 159,394
2025-06-30 $21,978,139 67,399
2025-03-31 $21,834,357 80,862
2024-12-31 $22,312,564 94,822
2024-09-30 $37,683,785 137,017
2024-06-30 $288,684 1,188
2024-03-31 $442,222 2,959
2023-12-31 $3,259,329 17,028
2023-06-30 $286,239 1,507
2023-03-31 $301,882 1,507
2022-12-31 $491,222 2,067
2022-09-30 $1,223,377 6,112